close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Laboratory Corp American Holdings (NY:LH)

275.66 -3.83 (-1.37%)
Official Closing Price Updated: 7:00 PM EDT, Oct 27, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Laboratory Corp American Holdings

< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Where Laboratory Corp Stands With Analysts
 
Via Benzinga
Singular Genomics Appoints Genomics Veteran Marcia Eisenberg, Ph.D., to Board of Directors
From Singular Genomics Systems, Inc.
Via GlobeNewswire
Expert Ratings for Laboratory Corp
 
Via Benzinga
Enzo Biochem Completes Sale of Clinical Laboratory to Labcorp
From Enzo Biochem, Inc.
Via GlobeNewswire
Visualizing The Entire S&P 500
One of the biggest challenges market analysts have is how to visualize the companies that make up the S&P 500. 
Via Talk Markets
Why Shares of Labcorp Dropped Monday
The company completed the spinoff of contract research organization Fortrea Holdings. 
Via The Motley Fool
Analyst Ratings for Laboratory Corp
 
Via Benzinga
Labcorp's Q1 Revenue Falls On Decline In COVID-19 Testing Sales
 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
 
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
 
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
 
Via Benzinga
Earnings Outlook For Laboratory Corp
 
Via Benzinga
This Foreboding Sign Looms Over Laboratory Corp's Chart
 
Via Benzinga
Why Is Enzo Biochem (ENZ) Stock Up 72% Today?
Enzo Biochem (ENZ) stock is rocketing higher on Friday with heavy trading after the company agreed to an asset sale with Labcorp (LH). 
Via InvestorPlace
Where Laboratory Corp Stands With Analysts
 
Via Benzinga
Fortrea Launches as Leading, Global Contract Research Organization Positioned to Bring Life-Changing Therapies to Patients Faster
From Fortrea Holdings Inc
Via GlobeNewswire
FDA Readies Proposal for Increased Oversight on Lab-developed Tests
The FDA is preparing to increase regulation of a widely used class of tests conducted by laboratories to detect cancer, measure cholesterol, and identify other health issues. The FDA is developing a... 
Via Benzinga
3 No-Brainer Stocks to Buy in a Correction
Stock market downturns present great opportunities to go shopping for wonderful stocks. 
Via The Motley Fool
Exact Sciences Serves Investors Exactly What They Wished For
Diagnostic and cancer test products provider Exact Sciences Corp. (NASDAQ: EXAS) saw its shares spike over 17% on its Q1 2023 earnings results. The 
Via MarketBeat
Earnings Scheduled For February 16, 2023
Companies Reporting Before The Bell • RELX (NYSE:RELX) is estimated to report earnings for its Fiscal Year 2022. • Coca-Cola Europacific (NASDAQ:CCEP) is expected to report earnings for its Fiscal Year... 
Via Benzinga
Earnings Preview: Laboratory Corp
 
Via Benzinga
3 Telemedicine Stocks to Watch as Healthcare Goes Digital
The telemedicine stocks discussed in the article offer incredible upside ahead in the fast-evolving telehealth sector 
Via InvestorPlace
7 Low-PE Ratio Blue-Chip Stocks Offering Both Quality and Value
Make your dollars go as far as possible (and relatively safely) with these low-PE ratio blue-chip stocks to buy. 
Via InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
The biggest pre-market stock movers for Friday are ready to go as we dive into the latest news for investors this morning! 
Via InvestorPlace
Why Enzo Biochem Stock Is Skyrocketing After Hours
Enzo Biochem Inc (NYSE: ENZ) shares are soaring in extended trading Thursday after the company agreed to sell its clinical lab to Laboratory Corporation Of America 
Via Benzinga
Ovia HealthTM Expands Digital Platform Capabilities to Include Menopause Tracking
From Labcorp
Via Business Wire
Labcorp Announces 2022 Fourth Quarter and Full-Year Results
From Labcorp
Via Business Wire
Labcorp Unveils New Name for Future Independent Clinical Development Business - Fortrea
From Labcorp
Via Business Wire
Down 40% in 2022, Can Exact Sciences Recover in 2023?
Investors are attracted to its leading position in the market for early cancer detection, but the persistent losses its been reporting are enough to make anyone nervous. 
Via The Motley Fool
< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today